The activity of azlocillin, a new semisynthetic penicillin, was determined against 582 clinical isolates of gram-negative bacilli and gram-positive cocci. Over 75% of the isolates ofPseudomonas aeruginosa were inhibited at a concentration of 12.5 ug or less per ml. Azlocillin is also active against indole-negative and -positive Proteus spp., inhibiting 98 and 71%, respectively, at a concentration of 12.5 ug or less per ml. Isolates of Klebsiella spp. and Enterobacter spp. showed less susceptibility than isolates of Escherichia coli and Serratia spp. Gram-positive cocci except penicillin G-resistant Staphylococcus aureus were susceptible to azlocillin. Azlocillin failed to inhibit the growth of gram-negative bacilli when large inocula were used. It was more active in alkaline pH, but the type of medium used had little effect on its activity. Azlocillin was more active than mezlocillin, ticarcillin, and carbenicillin and as active as BLP-1654 against isolates ofP. aeruginosa. It was not as active as mezlocillin against the majority of the other gram-negative bacilli.
Gram-negative bacilli, especially Klebsiella spp. and Pseudomonas aeruginosa, continue to be a major cause of infection among patients with malignant diseases and patients receiving immunosuppressive therapy (6, 7) . Some of these patients fail to improve even when an appropriate antibiotic is administered on the basis of in vitro susceptibility testing (2) . In general, penicillins have been more effective than other antibiotics against susceptible organisms in the compromised host (1) . Since penicillins have been more effective than other classes of antimicrobial agents for the treatment of such infections, new penicillin derivatives with broad-spectrum activity, particularly against gram-negative bacilli, are of special interest. Azlocillin, a new semisynthetic penicillin, is of interest because of its activity against these organisms and especially P. aeruginosa. Figure 1 shows the chemical structure of azlocillin (6[u-2-(2-oxoimidazolidine-1-carboxamido) -2 -phenylacetamido] -penicillanic acid, sodium salt). This report presents an in vitro evaluation of azlocillin and compares its activity with other semisynthetic penicillins, including another new derivative, mezlocillin.
MATERIALS AND METHODS Susceptibility tests were conducted on 479 clinical isolates of gram-negative bacilli and 99 clinical isolates of gram-positive cocci, using a dilution technique with an automatic microtiter system (Canalco, Autotiter Instruction Manual). All gram-negative bacilli and Staphylococcus aureus isolates to be tested were incubated in Mueller-Hinton broth (pH 7.4) for 18 h at 37°C. Streptococcus pyogenes and S. pneumoniae were incubated in tryptose phosphate broth. Approximately 105 colony-forming units (CFU) per ml was used as the inoculum for gramnegative bacilli and S. aureus. For the remaining gram-positive cocci, an inoculum of 106 CFU/ml was used for the in vitro susceptibility testing.
All gram-negative bacilli used in this study were cultured from blood specimens of patients who were hospitalized at this institution and had underlying malignant diseases. A total of 100 isolates each ofP. aeruginosa, Klebsiella spp., and Escherichia coli, 79 isolates of Proteus spp., 50 isolates each of Serratia spp., and Enterobacter spp. were used. All grampositive cocci used in this study were cultured from specimens obtained from hospitalized patients, most of whom did not have cancer. A total of 40 isolates of S. pyogenes, 9 isolates of S. pneumoniae, and 50 isolates of S. aureus were used. Isolates of S. aureus were divided according to their susceptibility to penicillin G. Those isolates that were inhibited by less than 0.10 jig/ml were selected as penicillin G susceptible and those isolates resistant to more than 25 ,ug/ml were selected as penicillin G resistant.
Organisms used for studies of the effect of inoculum size on the activity of azlocillin were incubated in Mueller-Hinton broth for 18 h at 37°C. It was assumed that approximately 108 CFU/ml were present after incubation, which was subsequently confirmed by subculturing 0.1-ml portions on sheep blood agar and performing colony counts after 14 
RESULTS
The in vitro susceptibility of azlocillin against gram-positive cocci and gram-negative bacilli is shown in Fig. 2 . At a concentration of 12.5 ,ug/ml, over 75% of the isolates of P. aeruginosa were inhibited. Both indole-negative and -positive Proteus spp. were susceptible to azlocillin, with 75% of P. mirabilis inhibited at 1.56 ug/ml and 71% of indole-positive Proteus spp. inhibited at 12.5 ,ug/ml. Azlocillin exhibited moderate activity against isolates of E. coli and Serratia spp., inhibiting 63 and 46%, respectively, at a concentration of 12.5 ,ig/ ml. Klebsiella spp. and Enterobacter spp. showed less activity with only 21 and 26%, respectively, inhibited at the same concentration of 12.5 ,ug/ml. All isolates of S. pyogenes were inhibited by a concentration of 0.10 ,tg or less per ml. However, only four of nine isolates ofS.
pneumoniae were inhibited at 0.10 ,ug/ml. The majority of the penicillin G-susceptible S. aureus were inhibited by 0.20 ,ug or less of azlocillin per ml, whereas the penicillin G-resistant S. aureus was also resistant to azlocillin. The MBC generally was the same as, or one concentration higher than, the MIC.
The effect of inoculum size on the MIC and MBC was determined for 10 isolates each of K. pneumoniae, E. coli, and P. aeruginosa. All of the isolates ofE. coli were completely inhibited at 6.25 ug/ml when an inoculum of 105 CFU/ml was used. At a concentration of 50 ,ug/ml or less, 8 of the 10 isolates ofK. pneumoniae and 8 of the 10 isolates of P. aeruginosa were inhibited when an inoculum of 105 CFU/ml was used. With the exception of one isolate of P. aeruginosa, all the isolates had similar MICs and MBCs. None of the isolates was inhibited at a concentration of 400 jig/ml when an inoculum of 107 CFU/ml was used.
The effect of pH on susceptibility of 10 isolates each of E. coli, K. pneumoniae, and P. aeruginosa to azlocillin is shown in Fig. 3 . The activity of azlocillin increased against all organisms as the pH became more alkaline. As shown in Fig. 4 , media variation had little effect on the activity of azlocillin. However, isolates of P. aeruginosa were slightly more susceptible in nutrient broth, whereas isolates of E. coli and K. pneumoniae were not.
The susceptibility of isolates of Enterobacteriaceae was determined for azlocillin, carbenicillin, mezlocillin, ticarcillin, and BLP-1654 (Fig. 5) . Mezlocillin was consistently more active than azlocillin. Mezlocillin was the most active penicillin against Klebsiella spp. Azlocillin was as active as BLP-1654 and inhibited 54% of the isolates at a concentration of 25 of the isolates were resistant to 25 lug of these penicillins per ml. Azlocillin inhibited fewer isolates of S. marcescens at a concentration of 12.5 ug/ml than the other penicillins. However, some of the isolates resistant to carbenicillin and ticarcillin were inhibited by azlocillin. Mezlocillin was the most active penicillin against Serratia spp., E. coli, and P. mirabilis. Azlocillin, carbenicillin, BLP1654, and ticarcillin had similar activity against isolates ofE. coli. All of these antibiotics were active against most of the isolates ofProteus mirabilis at a concentration of 3.12 utg/ml. At lower concentrations, azlocillin was the least active penicillin. Azlocillin also was less active than mezlocillin against indole-positive Proteus spp., but more active than BLP-1654. It inhibited 64% of these isolates at a concentration of 3.12 ,ug/ml. The activity of the five penicillins against isolates of P. aeruginosa is shown in Fig. 6 . Azlocillin and BLP-1654 were the most active penicillins and were substantially more active than carbenicillin. Mezlocillin and ticarcillin were intermediate in their activity. Eleven isolates of P. aeruginosa that were resistant to carbenicillin (MIC, -400 ,tg/ml) were tested for their susceptibility to the other penicillins (Table 1). Five isolates ofE. coli, five isolates of S. marcescens, and four isolates of Enterobacter spp. were also tested. Those isolates of P. aeruginosa, which were inhibited by 400 ,ug of carbenicillin per ml, were generally susceptible to the other penicillins, and azlocillin was the most active. Most of the isolates of P. aeruginosa resistant to 400 ,ug of carbenicillin per ml were also resistant to the other penicillins. All of the isolates of other gram-negative bacilli were not inhibited by 400 jig of any of these penicillins per ml.
DISCUSSION
Azlocillin is a new ureido-substituted penicillin with activity against gram-negative bacilli. In general, its spectrum of activity is similar to that of BLP-1654 (5). The only major advantage of azlocillin is its antipseudomonal activity, which is substantially greater than carbenicillin. Against most isolates ofP. aeruginosa, it is four times more active than ticarcillin. Another new penicillin, mezlocillin, has a broader spectrum of activity than azlocillin, but is not as active against P. aeruginosa. A major disadvantage of BLP-1654 was renal damage, which was observed in toxicology studies. Azlocillin M366, 1975) . Azlocillin was active against those isolates of P. aeruginosa that were only marginally susceptible to carbenicillin and ticarcillin. This could be of importance clinically, since it is difficult to achieve serum concentrations ofcarbenicillin of 400 pg/ml without toxicity.
Inoculum size had a major effect on the activity of azlocillin. It was inactive against all isolates ofE. coli, K. pneumoniae, and P. aeruginosa when a large inoculum was used. It has been suggested that a larger inoculum contains a greater number of resistant cells. This effect of inoculum variation has been observed by other investigations with other penicillins, including BLP-1654 and pirbenicillin (4, 5, 8, 9) . The clinical relevance of this observation is not clear.
The effect of pH on the activity of azlocillin is similar to the results obtained with other semisynthetic penicillins (3) . Its activity increases as the pH increases. Media variation had little effect on the activity of azlocillin. However, the activity of other penicillins, like BLP-1654 and pirbenicillin, is influenced by the type of medium utilized (4, 5) .
Azlocillin is an interesting semisynthetic penicillin, because it is more active than carbenicillin and ticarcillin against P. aeruginosa and has a somewhat broader spectrum of activity. Pharmacology studies indicate that adequate serum concentrations of this drug can be obtained, and preliminary therapeutic studies have been encouraging (H. Lode, U. Niestrath, P. Koeppe, and H. Langmaack, Prog. Abstr. Intersci. Conf. Antimicrob. Agents Chemother., 16th, Chicago, Ill., Abstr. 348, 1976). It is deserving of further investigation to ascertain its potential value for clinical therapeutic studies.
